Scholarlink

Introduction <p> Axillary lymph node metastasis (ALNM) from endometrial carcinoma is extremely rare, particularly in tumors with early-stage, endometrioid histology. The clinical characteristics, underlying mechanisms, and optimal management strategies for this rare metastatic pattern remain insufficiently defined.</p> Case presentation <p> We report a case of a 63-year-old woman diagnosed with FIGO 2023 stage IIB, grade 2 endometrioid endometrial carcinoma exhibiting mismatch repair deficiency (dMMR) and substantial lymphovascular space invasion (LVSI). She underwent surgery followed by adjuvant pelvic radiotherapy and vaginal brachytherapy. Approximately one year later, the patient developed isolated right axillary lymphadenopathy. Histopathological and immunohistochemical analyses confirmed metastatic endometrioid adenocarcinoma of uterine origin. The patient was treated with tislelizumab and lenvatinib but experienced progressive disease, with enlarging axillary nodes and new chest wall involvement. Salvage radiotherapy with a simultaneous integrated boost was administered and achieved tumor regression. A focused review of previously reported cases of axillary lymph node metastasis from endometrial carcinoma was conducted to summarize clinicopathologic features and treatment approaches.</p> Conclusion <p> This case highlights an unusual metastatic pattern of endometrial cancer and underscores the need for individualized risk stratification, long-term surveillance, and timely integration of local therapy when systemic treatment proves insufficient.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Isolated axillary metastasis from early-stage dMMR endometrial carcinoma: a case report and mini-review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月14日

查看全文
  • Yanying Yu,
  • Xiaoyan Chang,
  • Xiaorong Hou,
  • Fuquan Zhang

摘要

Introduction

Axillary lymph node metastasis (ALNM) from endometrial carcinoma is extremely rare, particularly in tumors with early-stage, endometrioid histology. The clinical characteristics, underlying mechanisms, and optimal management strategies for this rare metastatic pattern remain insufficiently defined.

Case presentation

We report a case of a 63-year-old woman diagnosed with FIGO 2023 stage IIB, grade 2 endometrioid endometrial carcinoma exhibiting mismatch repair deficiency (dMMR) and substantial lymphovascular space invasion (LVSI). She underwent surgery followed by adjuvant pelvic radiotherapy and vaginal brachytherapy. Approximately one year later, the patient developed isolated right axillary lymphadenopathy. Histopathological and immunohistochemical analyses confirmed metastatic endometrioid adenocarcinoma of uterine origin. The patient was treated with tislelizumab and lenvatinib but experienced progressive disease, with enlarging axillary nodes and new chest wall involvement. Salvage radiotherapy with a simultaneous integrated boost was administered and achieved tumor regression. A focused review of previously reported cases of axillary lymph node metastasis from endometrial carcinoma was conducted to summarize clinicopathologic features and treatment approaches.

Conclusion

This case highlights an unusual metastatic pattern of endometrial cancer and underscores the need for individualized risk stratification, long-term surveillance, and timely integration of local therapy when systemic treatment proves insufficient.